insights_auto
Why is SYRE down 4,26%?
Dive Deeperchevron_right
SYRE:NASDAQ
Spyre Therapeutics Inc
93,47 US$
arrow_downward
-4,26%(-4,16) 1D
93,47 US$
0,00% (0,00)
bedtimeAfter hours
Closed: 20 ნოე, 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SYRE...
Open
95,93 US$
High
99,56 US$
Low
93,22 US$
Mkt. cap
8,88 მლრდ.
Avg. vol.
1,05 მლნ.
Volume
805,36 ათ.
52-wk high
110,64 US$
52-wk low
23,01 US$
EPS
-3,22 US$
Beta
3,24
Shares outstanding
94,97 მლნ.
No. of employees
130
Open
95,93 US$
High
99,56 US$
Low
93,22 US$
Mkt. cap
8,88 მლრდ.
Avg. vol.
1,05 მლნ.
Volume
805,36 ათ.
52-wk high
110,64 US$
52-wk low
23,01 US$
EPS
-3,22 US$
Beta
3,24
Shares outstanding
94,97 მლნ.
No. of employees
130
News stories
From web sources and news partners
Nacionale
·
40 წუთის წინ
Is the stock market down for the year? Only the Nasdaq; the S&P 500 and Dow are barely up for 2026
TradingView
·
47 წუთის წინ
Wall Street ends sharply lower on AI selloff, S&P 500, Dow in correction
The Motley Fool
·
2 საათის წინ
Report: Goldman Sachs Predicts the S&P 500 Will Gain 26% in 12 Months
Traders Union
·
1 დღის წინ
S&P 500 falls 3.7% for second largest decline this year, Charlie Bilello notes
About Spyre Therapeutics Inc
CEO-
Employees130
Founded1 იან. 2013
HeadquartersWaltham, მასაჩუსეტსი, ამერიკის შეერთებული შტატები
SectorHealth Care
Industry-
Websitespyre.com